Envista (NYSE:NVST) Sets New 52-Week Low – Time to Sell?

Envista Holdings Co. (NYSE:NVST) reached a new 52-week low during trading on Friday . The stock traded as low as $14.82 and last traded at $15.13, with a volume of 290644 shares changing hands. The stock had previously closed at $16.10.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on NVST shares. Jefferies Financial Group lifted their target price on shares of Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. UBS Group lowered their target price on shares of Envista from $23.00 to $21.00 and set a “neutral” rating on the stock in a report on Monday, March 10th. Wells Fargo & Company set a $19.00 target price on Envista in a research report on Saturday, March 8th. JPMorgan Chase & Co. reduced their price target on Envista from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Thursday, March 6th. Finally, New Street Research set a $19.00 price objective on Envista in a report on Thursday, March 6th. Two analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, Envista currently has an average rating of “Hold” and an average price target of $20.18.

Envista Price Performance

The company has a market capitalization of $2.66 billion, a PE ratio of -2.38, a price-to-earnings-growth ratio of 1.27 and a beta of 1.12. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. The firm’s 50-day moving average is $19.18 and its 200-day moving average is $19.53.

Envista (NYSE:NVST) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. Equities analysts predict that Envista Holdings Co. will post 1 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Envista

A number of hedge funds have recently made changes to their positions in the business. Venturi Wealth Management LLC raised its position in Envista by 528.4% in the 4th quarter. Venturi Wealth Management LLC now owns 1,948 shares of the company’s stock worth $38,000 after purchasing an additional 1,638 shares during the period. GAMMA Investing LLC grew its stake in shares of Envista by 30.5% during the fourth quarter. GAMMA Investing LLC now owns 2,304 shares of the company’s stock valued at $44,000 after buying an additional 538 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of Envista in the fourth quarter worth about $53,000. Mitsubishi UFJ Trust & Banking Corp bought a new stake in shares of Envista in the 4th quarter valued at about $86,000. Finally, KBC Group NV boosted its holdings in Envista by 63.9% during the 4th quarter. KBC Group NV now owns 7,903 shares of the company’s stock valued at $152,000 after acquiring an additional 3,082 shares during the period.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.